Papillomavirus

ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc. Enter into Option Agreement for Treatment of Cervical Dysplasia

Retrieved on: 
Tuesday, January 14, 2020
Cancer, Infectious causes of cancer, RTT, Papillomavirus, Gynaecological cancer, Women's health, Cervical intraepithelial neoplasia, Cervical cancer, Human papillomavirus infection, Cervix, Preterm birth, HPV vaccine

Cervical dysplasia is a preliminary stage of cervical cancer, and its causes are predominantly due to persistent infections of human papillomaviruses (HPV) in the cervix.

Key Points: 
  • Cervical dysplasia is a preliminary stage of cervical cancer, and its causes are predominantly due to persistent infections of human papillomaviruses (HPV) in the cervix.
  • Excision surgery is the first choice for high-grade cervical dysplasia, but it has been reported that the surgery increases the risk of premature delivery.
  • At present, there is no medication for treating HPV in case of the low- and moderate-grade cervical dysplasia.
  • Established in April 2005, KinoPharma is a pharmaceutical company engaged in research and development of drugs in collaboration with Kyoto University.

Socioeconomic Factors Increasing Cervical Cancer Rates for Some in the U.S. Despite Downward Nationwide Trends

Retrieved on: 
Thursday, January 9, 2020
Public policy, Government, Healthcare reform, General Health, Health, Infectious causes of cancer, Clinical medicine, Medicine, RTT, Papillomavirus, Gynaecological cancer, Vaccines, Human papillomavirus infection, HPV vaccine, Cervical cancer, Cancer, Vaccine

To prevent these results, it is crucial that women keep themselves informed as recent cervical cancer testing recommendations2 and HPV vaccination age limits3 have changed.

Key Points: 
  • To prevent these results, it is crucial that women keep themselves informed as recent cervical cancer testing recommendations2 and HPV vaccination age limits3 have changed.
  • The U.S. Department of Health and Human Services recommends the following steps to help prevent cervical cancer 4:
    Get the HPV vaccine.
  • These tests can help find cervical cells that are infected with HPV or have other abnormalities before they turn into cervical cancer.
  • The American Cancer Society Guidelines for the Prevention and Early Detection of Cervical Cancer.

Global human papillomavirus vaccine market is expected to grow with a CAGR of 5.00% over the forecast period from 2019-2025

Retrieved on: 
Tuesday, December 31, 2019
Vaccines, Medicine, Clinical medicine, Cancer vaccines, Papillomavirus, Medical specialties, RTT, Papillomaviridae, Vaccine, HPV vaccine

The report on the global human papillomavirus vaccine market provides qualitative and quantitative analysis for the period from 2017 to 2025.

Key Points: 
  • The report on the global human papillomavirus vaccine market provides qualitative and quantitative analysis for the period from 2017 to 2025.
  • The report predicts the global human papillomavirus vaccine market to grow with a CAGR of 5.00% over the forecast period from 2019-2025.
  • The study on human papillomavirus vaccine market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.
  • The report on human papillomavirus vaccine market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global human papillomavirus vaccine market over the period of 2017 to 2025.

Asia-Pacific DNA Vaccines Market 2019-2027 - Surge in New Vaccine Development Drives the Market

Retrieved on: 
Monday, December 30, 2019
Drugs, Vaccination, Vaccines, Medical specialties, Vaccine, Virology, RTT, Papillomavirus

DUBLIN, Dec. 30, 2019 /PRNewswire/ -- The "Asia-Pacific DNA Vaccines Market 2019-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 30, 2019 /PRNewswire/ -- The "Asia-Pacific DNA Vaccines Market 2019-2027" report has been added to ResearchAndMarkets.com's offering.
  • The Asia-Pacific DNA vaccines market is expected to make progressive growth at a CAGR of 42.79% in terms of revenue throughout the estimated period of 2019-2027.
  • Japan, India, China, South Korea, Australia & New Zealand, ASEAN countries and countries in rest of APAC together constitute the market for DNA vaccines in the Asia-Pacific region.
  • The DNA vaccines market in China is mainly driven by the growing investments by the government of China for clinical trials and development of DNA vaccines towards the treatment of chronic diseases such as cancer, HPV, diabetes, etc.

Transgene Announces Financial Calendar for 2020

Retrieved on: 
Wednesday, December 18, 2019
Biotechnology, Health, Finance, Other Health, Pharmaceutical, Professional services, Stem cells, Oncology, Research, Infectious diseases, Hospitals, Genetics, Science, Clinical trials, Cancer, Branches of biology, Medicine, Gene delivery, Carcinogenesis, Infectious causes of cancer, Papillomavirus, Oncolytic virus, Human papillomavirus infection, Transgene, Virus, Vaccine

Transgene (Paris:TNG) (Euronext Paris: TNG) today announced its financial reporting dates for 2020:

Key Points: 
  • Transgene (Paris:TNG) (Euronext Paris: TNG) today announced its financial reporting dates for 2020:
    Transgene (Euronext: TNG) is a publicly traded French biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer and infectious diseases.
  • Transgenes programs utilize viral vector technology with the goal of indirectly or directly killing infected or cancerous cells.
  • The Companys clinical-stage programs include TG4001, a therapeutic vaccine against HPV-positive cancers and TG6002, an oncolytic virus for the treatment of solid tumors.
  • With its proprietary platform Invir.IO, Transgene builds on its expertise in viral vectors engineering to design a new generation of multifunctional oncolytic viruses.

Actor Ernie Hudson to serve as national spokesperson for Think About the Link

Retrieved on: 
Monday, December 16, 2019
Cancer, Viruses, RTT, Infectious causes of cancer, Medicine, Papillomavirus, Cancer vaccines, Vaccines, Human papillomavirus infection, HPV vaccine, Cancer prevention, Papillomaviridae

Hudson has always been a champion of his own health and wellness and is using his voice to amplify cancer prevention.

Key Points: 
  • Hudson has always been a champion of his own health and wellness and is using his voice to amplify cancer prevention.
  • The Prevent Cancer Foundation is proud to announce Hudson as a new spokesperson forThink About the Link,a campaign educating people on the link between certain viruses and cancer.
  • Hudson will be speaking out for cancer prevention as it relates to the human papillomavirus (HPV).
  • Hudson is now cancer-free and wants to spread the word about the importance of getting the HPV vaccine to prevent cancer.

Global Cervical Cancer Drugs Market Report 2020: Market was Valued $15.3 Billion in 2018 and is Expected to Grow to $17.9 billion Through 2022 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 11, 2019
Pharmaceutical, Health, Oncology, RTT, Infectious causes of cancer, Gynaecological cancer, Causes of death, Health, Epidemiology, Cervical cancer, Papillomavirus, Cancer, Cervical

The global cervical cancer drugs market was valued at about $15.3 billion in 2018 and is expected to grow to $17.9 billion at a CAGR of 4.0% through 2022.

Key Points: 
  • The global cervical cancer drugs market was valued at about $15.3 billion in 2018 and is expected to grow to $17.9 billion at a CAGR of 4.0% through 2022.
  • The cervical cancer drugs market consists of sales of cervical cancer drugs used for the treatment of cervical cancer in women.
  • The cervical cancer drugs market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.
  • The increasing prevalence of HIV (Human immunodeficiency virus) in women is driving the growth of the cervical cancer drugs market.

Brazil Human Papillomavirus Vaccine Market Trends & Analysis During the Forecast Period, 2019-2024 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 4, 2019
Health, Pharmaceutical, Cancer, Medicine, Papillomavirus, Clinical medicine, Infectious causes of cancer, RTT, Vaccination, Vaccines, Vaccine, HPV vaccine, Papillomaviridae, Human papillomavirus infection

The "Brazil Human Papillomavirus Vaccine Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Brazil Human Papillomavirus Vaccine Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
  • The country research report on Brazil human papillomavirus vaccine market is a customer intelligence and competitive study of the Brazil market.
  • The companies and dealers/distributors profiled in the report include manufacturers & suppliers of human papillomavirus vaccine market in Brazil.
  • 5) What are the modes of entering Brazil human papillomavirus vaccine market?

France Human Papillomavirus Vaccine Market Opportunities, Drivers & Restraints, 2019-2024 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 3, 2019
Health, General Health, Medicine, Clinical medicine, Vaccination, Cancer vaccines, Papillomavirus, Vaccines, Medical specialties, Vaccine, Virology, HPV vaccine, Papillomaviridae

The "France Human Papillomavirus Vaccine Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "France Human Papillomavirus Vaccine Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
  • The country research report on France human papillomavirus vaccine market is a customer intelligence and competitive study of the France market.
  • The companies and dealers/distributors profiled in the report include manufacturers & suppliers of human papillomavirus vaccine market in France.
  • 5) What are the modes of entering France human papillomavirus vaccine market?

India Human Papillomavirus Vaccine Market: Drivers, Restraints & Opportunities During the Forecast Period, 2019-2025 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 3, 2019
Infectious diseases, Pharmaceutical, Health, Vaccines, Medicine, Clinical medicine, Cancer vaccines, Papillomavirus, Medical specialties, HPV vaccine, RTT, Vaccine, Papillomaviridae

The country research report on India human papillomavirus vaccine market is a customer intelligence and competitive study of the India market.

Key Points: 
  • The country research report on India human papillomavirus vaccine market is a customer intelligence and competitive study of the India market.
  • The companies and dealers/distributors profiled in the report include manufacturers & suppliers of human papillomavirus vaccine market in India.
  • 4) What are the opportunities in India human papillomavirus vaccine market?
  • 5) What are the modes of entering India human papillomavirus vaccine market?